The Clinical Efficacy of Platelet-Rich Plasma versus Conventional Drug Injection in the Treatment of Knee Osteoarthritis: A Study Protocol for a Randomized Controlled Trial

Knee osteoarthritis is a common chronic degenerative joint disease in middle-aged and elderly people. Intra-articular injection for the treatment of knee osteoarthritis is a regularly utilized nonsurgical treatment in modern medicine. Hyaluronic acid (HA) and platelet-rich plasma (PRP) are two frequently employed intra-articular devices. Hyaluronic acid (HA) is an accepted nonsurgical treatment for symptomatic KOA, and platelet-rich plasma is a popular option in the treatment of KOA in recent years. The purpose of this research is to compare the efficacy and safety of intra-articular injection of platelet-rich plasma (PRP) versus hyaluronic acid (HA) on the pain score scale, knee function, and related inflammatory biomarkers in KOA patients using a clinical randomized controlled trial. Participants are being randomized into either the hyaluronic acid (HA) or into the platelet-rich plasma (PRP) group. All patients receive 4 weeks of treatment (once a week), and well-being support and quadriceps training (3 times a week). The primary outcomes are measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the visual analog scale (VAS). The secondary outcomes include the activities of daily living score, erythrocyte sedimentation rate, C-reactive protein testing, interleukin-6 levels, and X-ray examination. In order to monitor the occurrence of irregularities and abnormalities, patients are assessed at each visit, and restorative treatment is given if necessary. The results of this clinical trial will verify the efficacy of PRP and HA in the treatment of KOA and provide important evidence for the clinical treatment of KOA. The trial was enlisted at the Chinese Clinical Trial Registry on 26 September 2020 (ChiCTR2000038635).

[1]  J H Abbott,et al.  OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. , 2019, Osteoarthritis and cartilage.

[2]  C. McCulloch,et al.  Role of thigh muscle cross-sectional area and strength in progression of knee cartilage degeneration over 48 months - data from the Osteoarthritis Initiative. , 2016, Osteoarthritis and cartilage.

[3]  Masaaki Takahashi,et al.  Elevated erythrocyte sedimentation rate and high-sensitivity C-reactive protein in osteoarthritis of the knee: relationship with clinical findings and radiographic severity , 2016, Annals of clinical biochemistry.

[4]  K. Karuna,et al.  Intra-articular Hyaluronic Acid (HA) and Platelet Rich Plasma (PRP) injection versus Hyaluronic acid (HA) injection alone in Patients with Grade III and IV Knee Osteoarthritis (OA): A Retrospective Study on Functional Outcome , 2016, Malaysian orthopaedic journal.

[5]  T. Grzela,et al.  Hyaluronic Acid in Inflammation and Tissue Regeneration. , 2016, Wounds : a compendium of clinical research and practice.

[6]  Elena Losina,et al.  Number of Persons With Symptomatic Knee Osteoarthritis in the US: Impact of Race and Ethnicity, Age, Sex, and Obesity , 2016, Arthritis care & research.

[7]  M. Behzadifar,et al.  Efficacy of Platelet-Rich Plasma versus Hyaluronic Acid for treatment of Knee Osteoarthritis: A systematic review and meta-analysis , 2016, Electronic physician.

[8]  M. Filippo Evidence-Based Complementary and Alternative Medicine , 2016 .

[9]  B. Bach,et al.  Hyaluronic Acid versus Platelet-Rich Plasma , 2015, Orthopaedic Journal of Sports Medicine.

[10]  A. Reddi,et al.  Stimulation of the Superficial Zone Protein and Lubrication in the Articular Cartilage by Human Platelet-Rich Plasma , 2015, The American journal of sports medicine.

[11]  G. Orive,et al.  Morphogen and proinflammatory cytokine release kinetics from PRGF-Endoret fibrin scaffolds: evaluation of the effect of leukocyte inclusion. , 2015, Journal of biomedical materials research. Part A.

[12]  J. Belkora,et al.  Impact of socioeconomic factors on informed decision making and treatment choice in patients with hip and knee OA. , 2015, The Journal of arthroplasty.

[13]  L. Blizzard,et al.  Circulating C reactive protein in osteoarthritis: a systematic review and meta-analysis , 2013, Annals of the Rheumatic Diseases.

[14]  T. Pufe,et al.  Role of platelet-released growth factors in detoxification of reactive oxygen species in osteoblasts. , 2014, Bone.

[15]  R. Idrus,et al.  Cartilage Regeneration by Chondrogenic Induced Adult Stem Cells in Osteoarthritic Sheep Model , 2014, PloS one.

[16]  S Lohmander,et al.  OARSI guidelines for the non-surgical management of knee osteoarthritis. , 2014, Osteoarthritis and cartilage.

[17]  Mikaël M. Martino,et al.  Growth Factors Engineered for Super-Affinity to the Extracellular Matrix Enhance Tissue Healing , 2014, Science.

[18]  T. Vos,et al.  The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study , 2014, Annals of the rheumatic diseases.

[19]  Vasili Karas,et al.  The Anti-inflammatory and Matrix Restorative Mechanisms of Platelet-Rich Plasma in Osteoarthritis , 2014, The American journal of sports medicine.

[20]  M. Marcacci,et al.  Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration , 2013, Knee Surgery, Sports Traumatology, Arthroscopy.

[21]  G. Orive,et al.  Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. , 2013, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[22]  N. Willits,et al.  Synovial fluid growth factor and cytokine concentrations after intra-articular injection of a platelet-rich product in horses. , 2013, Veterinary journal.

[23]  S. Percival,et al.  Hyaluronic Acid (HA) Viscosupplementation on Synovial Fluid Inflammation in Knee Osteoarthritis: A Pilot Study , 2013, The open orthopaedics journal.

[24]  N. Marwaha,et al.  Treatment With Platelet-Rich Plasma Is More Effective Than Placebo for Knee Osteoarthritis , 2013, The American journal of sports medicine.

[25]  L. Miller,et al.  US-Approved Intra-Articular Hyaluronic Acid Injections are Safe and Effective in Patients with Knee Osteoarthritis: Systematic Review and Meta-Analysis of Randomized, Saline-Controlled Trials , 2013 .

[26]  F. Cicuttini,et al.  Associations between serum levels of inflammatory markers and change in knee pain over 5 years in older adults: a prospective cohort study , 2012, Annals of the rheumatic diseases.

[27]  S. Reitinger,et al.  Hyaluronan, a Ready Choice to Fuel Regeneration: A Mini-Review , 2012, Gerontology.

[28]  J. Reinhardt,et al.  Evaluation of functional outcomes of physical rehabilitation and medical complications in spinal cord injury victims of the Sichuan earthquake. , 2012, Journal of rehabilitation medicine.

[29]  T. Wong,et al.  Hyaluronan Regulates Cell Behavior: A Potential Niche Matrix for Stem Cells , 2012, Biochemistry research international.

[30]  F. Berenbaum,et al.  Osteoarthritis: an update with relevance for clinical practice , 2011, The Lancet.

[31]  G. Hawker,et al.  Osteoarthritis year 2010 in review: non-pharmacologic therapy. , 2011, Osteoarthritis and cartilage.

[32]  Johanne Martel-Pelletier,et al.  Role of proinflammatory cytokines in the pathophysiology of osteoarthritis , 2011, Nature Reviews Rheumatology.

[33]  R. Cugat,et al.  Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life , 2011, Archives of Orthopaedic and Trauma Surgery.

[34]  M. Galeazzi,et al.  Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes , 2009, Journal of cellular biochemistry.

[35]  L. Punzi,et al.  Value of C reactive protein in the assessment of erosive osteoarthritis of the hand , 2005, Annals of the rheumatic diseases.

[36]  Ye Jian Application of Visual Analogue Scale measurement to evaluation of clinical curative effect femoral head necrosis , 2003 .

[37]  E. Hedbom,et al.  Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation , 2002, Cellular and Molecular Life Sciences CMLS.

[38]  C. Goldsmith,et al.  Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. , 1988, The Journal of rheumatology.